Related Experiment Videos
Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
Abstract:
The metabolism of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) has been studied in rat brain mitochondrial incubation mixtures. The 1-methyl-4-phenylpyridinium species MPP+ has been characterized by chemical ionization mass spectral and 1H NMR analysis. Evidence also was obtained for the formation of an intermediate product which, with the aid of deuterium incorporation studies, was tentatively identified as the alpha-carbon oxidation product, the 1-methyl-4-phenyl-2,3-dihydropyridinium species MPDP+. Comparison of the diode array UV spectrum of this metabolite with that of the synthetic perchlorate salt of MPDP+ confirmed this assignment. The oxidation of MPTP to MPDP+ but not of MPDP+ to MPP+ is completely inhibited by 10(-7) M pargyline. MPDP+, on the other hand, is unstable and rapidly undergoes disproportionation to MPTP and MPP+. Based on these results, we speculate that the neurotoxicity of MPTP is mediated by its intraneuronal oxidation to MPDP+, a reaction which appears to be catalyzed by MAO. The interactions of MPDP+ and/or MPP+ with dopamine, a readily oxidizable compound present in high concentration in the nigrostriatum, to form neurotoxic species may account for the selective toxic properties of the parent drug.
Insights
The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is metabolized to MPDP+ and MPP+ in rat brain mitochondria. This metabolism, particularly the oxidation to MPDP+, is inhibited by pargyline, suggesting a role in MPTP neurotoxicity.
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a selective nigrostriatal neurotoxin.
- Understanding MPTP's metabolic pathway is crucial for elucidating its mechanism of neurotoxicity.
Purpose of the Study:
- To investigate the metabolic fate of MPTP in rat brain mitochondrial incubation mixtures.
- To identify and characterize the metabolites of MPTP, including intermediate products.
- To explore the role of specific enzymes and reaction mechanisms in MPTP metabolism.
Main Methods:
- Incubation of MPTP with rat brain mitochondria.
- Characterization of metabolites using chemical ionization mass spectrometry and 1H NMR.
- Deuterium incorporation studies to identify intermediate products.
- UV spectroscopy for metabolite identification.
- Enzyme inhibition studies using pargyline.
Main Results:
- MPTP is metabolized to 1-methyl-4-phenylpyridinium (MPP+) and an intermediate, tentatively identified as 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+).
- The oxidation of MPTP to MPDP+ is inhibited by pargyline, suggesting MAO involvement.
- MPDP+ is unstable and disproportionates to MPTP and MPP+.
- MPDP+ and/or MPP+ interactions with dopamine may contribute to MPTP's selective neurotoxicity.
Conclusions:
- MPTP neurotoxicity is likely mediated by intraneuronal oxidation to MPDP+, catalyzed by MAO.
- The formation of toxic species through interactions of MPDP+ and/or MPP+ with dopamine explains MPTP's selective action.